Table 1.
Secondary OCI∗ | Cryptogenic OCI | |
---|---|---|
Evidence of liver injury | ||
ALT elevated | No | Yes |
Histological lesions | ||
Inflammatory: minimal to mod. | Occasional | Frequent |
Fibrotic: minimal to severe | Frequent | Frequent |
Organs involved | ||
Liver | Yes | Yes |
Lymphatic system (PBMC) | Yes | Yes |
Anti-HCV detection | Positive | Negative∗∗ |
HCV-RNA detection | ||
Serum | Yes | Yes |
PBMC | Yes | Yes |
Liver | Yes | Yes |
Longevity of persistence | At least 9 years | Unknown |
∗Secondary OCI: residual infection continuing after spontaneous resolution or after achieving apparent SVR following HCV therapy.
∗∗Antibodies against HCV can be detected in up to 40% in cryptogenic OCI.
+Adopted from Pham et al. [19], Liver International, 2010; 502-11.